Globus Medical (GMED) Shares Outstanding (Diluted Average) (2011 - 2026)

Globus Medical has reported Shares Outstanding (Diluted Average) for 14 years, with the latest figure at $138.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 1.13% year-over-year to $138.2 million; the trailing twelve-month figure through Mar 2026 stood at $138.2 million (down 1.13% YoY), and the FY2025 full-year result was $137.1 million, down 0.59% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $138.2 million, up from $137.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $139.8 million in Q1 2025, with the low at $114.6 million in Q4 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $133.5 million across 4 years, with a median of $137.9 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) increased 20.27% — and 2026, when it dropped 1.13%.
• Globus Medical's Shares Outstanding (Diluted Average) stood at $114.6 million in 2023, then gained by 20.27% to $137.9 million in 2024, then decreased by 0.59% to $137.1 million in 2025, then grew by 0.83% to $138.2 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $138.2 million (Q1 2026), $137.1 million (Q4 2025), and $139.8 million (Q1 2025), per Business Quant data.